DE60305727D1 - Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie - Google Patents

Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie

Info

Publication number
DE60305727D1
DE60305727D1 DE60305727T DE60305727T DE60305727D1 DE 60305727 D1 DE60305727 D1 DE 60305727D1 DE 60305727 T DE60305727 T DE 60305727T DE 60305727 T DE60305727 T DE 60305727T DE 60305727 D1 DE60305727 D1 DE 60305727D1
Authority
DE
Germany
Prior art keywords
prophylaxis
treatment
hypoestoxides
hyperlipidemia
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60305727T
Other languages
English (en)
Other versions
DE60305727T2 (de
Inventor
J Nchekwube
A Ojo-Amaize
B Cottam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paraquest Inc
Original Assignee
Paraquest Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paraquest Inc filed Critical Paraquest Inc
Application granted granted Critical
Publication of DE60305727D1 publication Critical patent/DE60305727D1/de
Publication of DE60305727T2 publication Critical patent/DE60305727T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60305727T 2002-10-28 2003-10-28 Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie Expired - Fee Related DE60305727T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42153302P 2002-10-28 2002-10-28
US421533P 2002-10-28
PCT/US2003/034157 WO2004039362A2 (en) 2002-10-28 2003-10-28 Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia

Publications (2)

Publication Number Publication Date
DE60305727D1 true DE60305727D1 (de) 2006-07-06
DE60305727T2 DE60305727T2 (de) 2007-05-31

Family

ID=32230237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60305727T Expired - Fee Related DE60305727T2 (de) 2002-10-28 2003-10-28 Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie

Country Status (9)

Country Link
US (1) US20040087553A1 (de)
EP (1) EP1558240B1 (de)
CN (1) CN1731992A (de)
AT (1) ATE327749T1 (de)
AU (1) AU2003286721A1 (de)
BR (1) BR0306632A (de)
CA (1) CA2509834A1 (de)
DE (1) DE60305727T2 (de)
WO (1) WO2004039362A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229979B2 (en) * 2003-06-23 2007-06-12 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents
US20060094695A1 (en) * 2004-11-02 2006-05-04 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use in the prophylaxis and treatment of obesity
WO2016144441A1 (en) * 2015-03-09 2016-09-15 Immune Modulation, Inc. Hypoestoxide, derivatives, related compounds, and agonists thereof for treatment or prevention of neurodegenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US6001871A (en) * 1998-01-15 1999-12-14 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as antiviral agents
US5994328A (en) * 1998-01-14 1999-11-30 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as anticancer agents
US5801193A (en) * 1997-04-15 1998-09-01 Immune Modulation, Inc. Compositions and methods for immunosuppressing
US6242484B1 (en) * 1999-07-06 2001-06-05 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use of antiparasitic agents

Also Published As

Publication number Publication date
DE60305727T2 (de) 2007-05-31
CA2509834A1 (en) 2004-05-13
WO2004039362A2 (en) 2004-05-13
WO2004039362A3 (en) 2004-07-08
US20040087553A1 (en) 2004-05-06
EP1558240B1 (de) 2006-05-31
CN1731992A (zh) 2006-02-08
AU2003286721A1 (en) 2004-05-25
ATE327749T1 (de) 2006-06-15
BR0306632A (pt) 2004-09-28
EP1558240A2 (de) 2005-08-03

Similar Documents

Publication Publication Date Title
SE0203713D0 (sv) Novel compounds
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
DE50310516D1 (de) Fredericamycin-derivate
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
FI20012510A (fi) Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina
DE60118003D1 (de) Harnstoffderivate und ihre verwendung
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
TW200603823A (en) Novel use of peptide compounds for treating essential tremor and other tremor syndromes
BRPI0410727A (pt) composto, composição farmacêutica, e, uso de um composto
HRP20050103A2 (en) N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
DE60322075D1 (de) Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
MXPA05013226A (es) Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas.
EA200601120A1 (ru) N-арилпиперидинзамещённые бифинилкарбоксамиды в качестве ингибиторов аполипопротеина в
ES2345882T3 (es) Nuevos compuestos y su uso como moduladores de ppar.
DE60329326D1 (de) Tace inhibitoren
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
ATE327749T1 (de) Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie
EA200600439A1 (ru) 4- ((феноксиалкил)тио) феноксиуксусные кислоты и аналоги
SE0301883D0 (sv) New use II

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee